Saroja Pharma Industries India Limited (NSE:SAROJA)

NSE:SAROJA Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	10.34	8.78	10.61	11.4	7.31
Depreciation & Amortization	1.14	0.94	0.65	0.42	0.21
Other Amortization	-	0.01	0.01	0.04	0.02
Other Operating Activities	13.71	14.18	13.15	7.93	3.3
Change in Accounts Receivable	-103.38	-51.32	28.72	-67.56	-29.63
Change in Inventory	2.99	34.68	-33.99	1.9	-3.89
Change in Accounts Payable	80.4	-2.54	5.58	11.55	13.97
Change in Other Net Operating Assets	6.28	5.53	-2.8	-2.41	-1.75
Operating Cash Flow	11.48	10.25	21.93	-36.74	-10.46
Operating Cash Flow Growth	12.05%	-53.27%	-	-	-
Capital Expenditures	-25.95	-47.29	-37.26	-3.02	-0.54
Sale (Purchase) of Real Estate	-	-	-10.08	-0.06	-
Investment in Securities	-1.42	-0.57	-1.03	-0.37	-
Other Investing Activities	0.36	0.24	0.13	0.1	0.04
Investing Cash Flow	-27.01	-47.62	-48.25	-3.35	-0.5
Long-Term Debt Issued	37.21	-	-	31.21	13
Long-Term Debt Repaid	-	-44.54	-	-	-
Net Debt Issued (Repaid)	37.21	-44.54	-	31.21	13
Issuance of Common Stock	-	86.77	-	19.5	-
Other Financing Activities	-21.59	-5.28	27.31	-8.01	-2.75
Financing Cash Flow	15.63	36.95	27.31	42.7	10.26
Miscellaneous Cash Flow Adjustments	-0	-	0	-	-
Net Cash Flow	0.1	-0.42	1	2.61	-0.71
Free Cash Flow	-14.46	-37.04	-15.34	-39.76	-11.01
Free Cash Flow Margin	-2.69%	-9.11%	-3.06%	-7.15%	-3.00%
Free Cash Flow Per Share	-3.60	-10.49	-5.22	-13.83	-4.05
Cash Interest Paid	12.16	12.76	9.95	6.66	2.63
Cash Income Tax Paid	4.17	3.33	4.22	4.38	3
Levered Free Cash Flow	-28.94	-51.73	-28.35	-49.42	-14.18
Unlevered Free Cash Flow	-21.33	-43.73	-22.13	-45.26	-12.52
Change in Working Capital	-13.71	-13.66	-2.5	-56.53	-21.3

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.